{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:46:40Z","timestamp":1791103600435,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.purol.2010.08.060","type":"journal-article","created":{"date-parts":[[2010,10,23]],"date-time":"2010-10-23T04:29:40Z","timestamp":1287808180000},"page":"995-1002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Syndrome de l\u2019intestin irritable, syndrome du releveur, proctalgie fugace et douleurs pelvip\u00e9rin\u00e9ales chroniques"],"prefix":"10.1016","volume":"20","author":[{"given":"Alain","family":"Watier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Rigaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Labat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2010.08.060_bib0005","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1365-2036.2005.02671.x","article-title":"Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey","volume":"22","author":"Andrews","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.purol.2010.08.060_bib0010","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1053\/gast.2002.37095","article-title":"AGA technical review on irritable bowel syndrome","volume":"123","author":"Drossman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.purol.2010.08.060_bib0015","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.purol.2010.08.060_bib0020","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/gut.33.6.818","article-title":"Defecation frequency and timing, and stool form in the general population-a prospective study","volume":"33","author":"Heaton","year":"1992","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.purol.2010.08.060_bib0025","first-page":"S1","article-title":"An evidence-based systematic review on the management of irritable bowel syndrome. American College of Gastroenterology Task Force on IBS","volume":"194","author":"Brandt","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.purol.2010.08.060_bib0030","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1111\/j.1572-0241.2002.07027.x","article-title":"The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review","volume":"97","author":"Cash","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.purol.2010.08.060_bib0035","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III Process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.purol.2010.08.060_bib0040","series-title":"Functional pain syndromes. Presentation and pathophysiology","first-page":"87","article-title":"Irritable bowel syndrome and related functional disorders","author":"Chang","year":"2009"},{"key":"10.1016\/j.purol.2010.08.060_bib0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11724-007-0048-1","article-title":"Physiopathologie des douleurs pelvi-p\u00e9rin\u00e9ales","volume":"20","author":"Watier","year":"2007","journal-title":"Doul Analg"},{"key":"10.1016\/j.purol.2010.08.060_bib0050","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1053\/j.gastro.2006.10.026","article-title":"Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders","volume":"131","author":"Mayer","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.purol.2010.08.060_bib0055","series-title":"Presentation and pathophysiology","first-page":"265","article-title":"Autononomic nervous system dysfunction functional pain syndromes","author":"J\u00e4nig","year":"2009"},{"key":"10.1016\/j.purol.2010.08.060_bib0060","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s10620-006-9306-y","article-title":"Studying the overlap between IBS and GERD: a systematic review of the literature","volume":"51","author":"Nastaskin","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.purol.2010.08.060_bib0065","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/j.1572-0241.2003.07699.x","article-title":"Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea","volume":"98","author":"Talley","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.purol.2010.08.060_bib0070","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1572-0241.1999.01440.x","article-title":"Symptom differences in moderate to severe IBS patients based on predominant bowel habit","volume":"94","author":"Schmulson","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.purol.2010.08.060_bib0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"Yunus","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.purol.2010.08.060_bib0080","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.pain.2009.12.005","article-title":"Central and peripheral hypersensitivity in irritable bowel syndrome","volume":"148","author":"Zhou","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.purol.2010.08.060_bib0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pain.2009.10.005","article-title":"Widespread hypersensitivity is related to altered pain inhibition processes in irritable bowel syndrome","volume":"148","author":"Piche","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.purol.2010.08.060_bib0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pain.2008.12.027","article-title":"Deficiency in endogenous modulation of prolonged heat pain in patients with irritable bowel syndrome and temporomandibular disorder","volume":"143","author":"King","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.purol.2010.08.060_bib0095","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jpsychores.2008.02.021","article-title":"Somatic comorbidities of irritable bowel syndrome: a systematic analysis","volume":"64","author":"Riedl","year":"2008","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.purol.2010.08.060_bib0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2002.32392","article-title":"Systemic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?","volume":"122","author":"Whitehead","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.purol.2010.08.060_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11608-009-0243-z","article-title":"Le syndrome du c\u00f4lon irritable et les troubles v\u00e9sicosphinct\u00e9riens","volume":"4","author":"Watier","year":"2009","journal-title":"Pelvi-P\u00e9rin\u00e9ologie"},{"key":"10.1016\/j.purol.2010.08.060_bib0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2036.2007.03399.x","article-title":"Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome","volume":"26","author":"Thabane","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.purol.2010.08.060_bib0115","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/ije\/31.6.1219","article-title":"Psychosocial risk factors for the onset of abdominal pain. Results from a large prospective population-based study","volume":"31","author":"Halder","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.purol.2010.08.060_bib0120","doi-asserted-by":"crossref","first-page":"828","DOI":"10.7326\/0003-4819-113-11-828","article-title":"Sexual and physical abuse in women with functional or organic gastrointestinal disorders","volume":"113","author":"Drossman","year":"1990","journal-title":"Ann Int Med"},{"key":"10.1016\/j.purol.2010.08.060_bib0125","doi-asserted-by":"crossref","first-page":"782","DOI":"10.7326\/0003-4819-123-10-199511150-00007","article-title":"Sexual and physical abuse and gastrointestinal illness. Review and recommendations","volume":"123","author":"Drossman","year":"1995","journal-title":"Ann Int Med"},{"key":"10.1016\/j.purol.2010.08.060_bib0130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF00346219","article-title":"Prevalence of sexual abuse among patients with functional disorders of the lower gastrointestinal tract","volume":"10","author":"Leroi","year":"1995","journal-title":"Int J Colorect"},{"key":"10.1016\/j.purol.2010.08.060_bib0135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1524838007303240","article-title":"Relationship of abuse history to functional gastrointestinal disorders and symptoms: some possible mediating mechanisms","volume":"8","author":"Leserman","year":"2007","journal-title":"Trauma Violence Abuse"},{"key":"10.1016\/j.purol.2010.08.060_bib0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.0269-2813.2004.01862.x","article-title":"Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome","volume":"19","author":"Bijkerk","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.purol.2010.08.060_bib0145","doi-asserted-by":"crossref","unstructured":"Quartero AO, Meineche-Schmidt V, Muris J, Rubin G, de Wit N. Bulking agents, antispasmodic and andidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2005:CD003460.","DOI":"10.1002\/14651858.CD003460.pub2"},{"key":"10.1016\/j.purol.2010.08.060_bib0150","article-title":"Pharmacotherapy for functional somatic condition functional pain syndromes","author":"Lydiard","year":"2009"},{"issue":"Suppl. 1","key":"10.1016\/j.purol.2010.08.060_bib0155","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.14309\/00000434-200809001-01230","article-title":"The efficacy of probiotics in the therapy of irritable bowel syndrome (IBS): a systematic review (abstract)","volume":"103","author":"Moayyedi","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.purol.2010.08.060_bib0160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1542-3565(03)70038-X","article-title":"Effects of venlafaxine, buspirone and placebo on colonic sensorimotor functions in healthy humans","volume":"1","author":"Chial","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.purol.2010.08.060_bib0165","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/gut.2006.110858","article-title":"Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome","volume":"56","author":"Houghton","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.purol.2010.08.060_bib0170","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-2036.2005.02685.x","article-title":"Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome","volume":"22","author":"Lee","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.purol.2010.08.060_bib0175","first-page":"491","article-title":"Cognitive-behavioral treatment of functional pain disorders functional pain syndromes","author":"Lackner","year":"2009"},{"issue":"Suppl. 1","key":"10.1016\/j.purol.2010.08.060_bib0180","first-page":"S477","article-title":"Efficacy of psychological therapies in irritable bowel syndrome: systematic review and meta-analysis","volume":"103","author":"Ford","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.purol.2010.08.060_bib0185","doi-asserted-by":"crossref","unstructured":"Lim B, Manheimer E, Lao L et al. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2006;(4) [Art. No: CD005111]. DOI: 10.1002\/14651858.CD005111.pub2","DOI":"10.1002\/14651858.CD005111.pub2"},{"key":"10.1016\/j.purol.2010.08.060_bib0190","doi-asserted-by":"crossref","unstructured":"Liu JP, Yang M, Liu YX et al. Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2006;(1):CD004116. DOI: 10.1002\/14651858.CD004116.pub2","DOI":"10.1002\/14651858.CD004116.pub2"},{"key":"10.1016\/j.purol.2010.08.060_bib0195","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7326\/0003-4819-145-8-200610170-00004","article-title":"The effect of a nonabsorbed oral antibiotic on the symptoms of the irritable bowel syndrome: a randomized trial","volume":"145","author":"Pimentel","year":"2006","journal-title":"Ann Int Med"},{"key":"10.1016\/j.purol.2010.08.060_bib0200","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.coph.2007.09.012","article-title":"Novel therapeutic approaches in IBS","volume":"7","author":"Bradesi","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.purol.2010.08.060_bib0205","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1365-2036.2006.02940.x","article-title":"Pilot study of the efficacy of rencapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome","volume":"23","author":"Tack","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.purol.2010.08.060_bib0210","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2036.2007.03398.x","article-title":"Effect of long-term treatment with octreotide on rectal sensitivity in patients with non-constipated irritable bowel syndrome","volume":"26","author":"Klooker","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.purol.2010.08.060_bib0215","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2165\/00003495-200666080-00004","article-title":"Irritable bowel syndrome: recent and novel therapeutic approaches","volume":"66","author":"Andresen","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.purol.2010.08.060_bib0220","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.42.6.845","article-title":"Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome","volume":"42","author":"Fukudo","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.purol.2010.08.060_bib0225","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.gastro.2007.06.067","article-title":"Effect of 5\u00a0days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome","volume":"133","author":"Andresen","year":"2007","journal-title":"Gastroenterol"},{"key":"10.1016\/j.purol.2010.08.060_bib0230","first-page":"796","article-title":"The impact of patient-centered care on outcomes","volume":"49","author":"Stewart","year":"2000","journal-title":"J Fam Pract"},{"key":"10.1016\/j.purol.2010.08.060_bib0235","series-title":"Textbook of Gastroenterology","first-page":"636","article-title":"Psychosocial factors in the care of patients with GI disorders","author":"Drossman","year":"2003"},{"key":"10.1016\/j.purol.2010.08.060_bib0240","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/gut.43.2.256","article-title":"Level of chronic life stress predicts clinical outcome in irritable bowel syndrome","volume":"43","author":"Bennett","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.purol.2010.08.060_bib0245","first-page":"336","article-title":"Optimizing patient care: the psychological interview in irritable bowel syndrome","volume":"5","author":"Chang","year":"2002","journal-title":"Clin Perspectives"},{"key":"10.1016\/j.purol.2010.08.060_bib0250","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2982.2005.00745.x","article-title":"Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review","volume":"18","author":"Park","year":"2006","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.purol.2010.08.060_bib0255","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1365-2222.2007.02727.x","article-title":"Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia","volume":"37","author":"Zuo","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.purol.2010.08.060_bib0260","doi-asserted-by":"crossref","unstructured":"Evans BW, Clark WK, Moore DJ, Whorwell PJ. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database Syst Rev 2007(4):CD003960.DOI: 10.1002\/14651858.CD003960.pub3","DOI":"10.1002\/14651858.CD003960.pub3"},{"key":"10.1016\/j.purol.2010.08.060_bib0265","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.52.5.671","article-title":"An Asia-Pacific, double blind placebo controlled randomised study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome","volume":"52","author":"Kellow","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.purol.2010.08.060_bib0270","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1046\/j.1365-2036.2001.01094.x","article-title":"Tegaserod, a 5-HT4\u00a0receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation","volume":"15","author":"M\u00fcller-Lissner","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.purol.2010.08.060_bib0275","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1053\/j.gastro.2007.04.022","article-title":"Lubiprostone significantly improves symptom relief rates in adults with irritable bowel syndrome and constipation (IBS-C): data from two twelve-week, randomized, placebo-controlled double-blind trials","volume":"132","author":"Drossman","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.purol.2010.08.060_bib0280","unstructured":"Valancogne G, Watier A. La constipation dyssynergique. Pelvi-P\u00e9rin\u00e9ologie 2010 (sous presse)."},{"key":"10.1016\/j.purol.2010.08.060_bib0285","unstructured":"Guillarme L. R\u00e9\u00e9ducation thoraco-abdomino-pelvienne par le concept Abdo-Mg. Ed Frison Roche, Paris 2004, 502\u00a0pages. ISBN: 9782876714472."},{"issue":"Suppl. 3","key":"10.1016\/j.purol.2010.08.060_bib0290","first-page":"S11","article-title":"Loperamide: a pharmacological review","volume":"7","author":"Baker","year":"2007","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.purol.2010.08.060_bib0295","first-page":"15","article-title":"Alosetron: an effective treatment for diarrhea-predominant irritable bowel syndrome","volume":"3","author":"Harris","year":"2007","journal-title":"Womens Health"},{"key":"10.1016\/j.purol.2010.08.060_bib0300","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/j.1572-0241.2007.01282.x","article-title":"A randomized double-blind placebo-controlled study to assess efficacy and safety of 0.5mg and 1mg alosetron in women with severe diarrhea-predominant IBS","volume":"102","author":"Krause","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.purol.2010.08.060_bib0305","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S1542-3565(04)00284-8","article-title":"Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: analysis of two controlled trials","volume":"2","author":"Lembo","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.purol.2010.08.060_bib0310","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/j.1572-0241.2001.04128.x","article-title":"Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome","volume":"96","author":"Lembo","year":"2001","journal-title":"Am J Gastrol"},{"key":"10.1016\/j.purol.2010.08.060_bib0315","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1365-2036.2004.02267.x","article-title":"Meta-analysis: the treatment of irritable bowel syndrome","volume":"20","author":"Lesbros-Pantoflickova","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.purol.2010.08.060_bib0320","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2036.2001.00937.x","article-title":"Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome","volume":"15","author":"Poynard","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.purol.2010.08.060_bib0325","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tips.2006.05.004","article-title":"Antidepressants and pain","volume":"27","author":"Micc","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.purol.2010.08.060_bib0330","series-title":"Psychotropic drugs and management of patients with functional gastrointestinal disorders. Advanced therapy in gastroenterology and liver disease","author":"Chang","year":"2004"},{"key":"10.1016\/j.purol.2010.08.060_bib0335","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","article-title":"Treatment of functional gastrointestinal disorders with antidepressans: a meta-analysis","volume":"108","author":"Jackson","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.purol.2010.08.060_bib0340","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/j.1572-0241.2003.07716.x","article-title":"A randomized controlled trial of cognitive behavior therapy relaxation training and routine clinical care for the irritabler bowel syndrome","volume":"98","author":"Boyce","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.purol.2010.08.060_bib0345","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0016-5085(03)00669-3","article-title":"Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders","volume":"125","author":"Drossman","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.purol.2010.08.060_bib0350","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cgh.2008.03.004","article-title":"Self-administered cognitive behavior therapy for moderate to severe irritable bowel: syndrome clinical efficacy, tolerability, feasibility","volume":"6","author":"Lackner","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.purol.2010.08.060_bib0355","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/00207140902881098","article-title":"Hypnotherapy for functional gastrointestinal disorders: a review","volume":"57","author":"Miller","year":"2009","journal-title":"Int J Clin Exp Hypn"},{"key":"10.1016\/j.purol.2010.08.060_bib0360","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2036.2006.03028.x","article-title":"Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome","volume":"24","author":"Wilson","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.purol.2010.08.060_bib0365","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0006-3223(99)00009-8","article-title":"Does stress damage the brain?","volume":"45","author":"Bremmer","year":"1999","journal-title":"Biol Psychi"},{"key":"10.1016\/j.purol.2010.08.060_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-5618.2008.00435.x","article-title":"Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder","volume":"10","author":"Konarski","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.purol.2010.08.060_bib0375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PSY.0b013e31818d1e02","article-title":"Patients with pain disorder show gray-matter loss in pain-processing structures: a voxel-based morphometric study","volume":"71","author":"Valet","year":"2009","journal-title":"Psychosom Med"},{"key":"10.1016\/j.purol.2010.08.060_bib0380","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1073858408317242","article-title":"Cognitive role of neurogenesis in depresion and antidepressant treatment","volume":"14","author":"Perera","year":"2008","journal-title":"Neuroscientist"},{"key":"10.1016\/j.purol.2010.08.060_bib0385","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.purol.2010.08.060_bib0390","unstructured":"Wald, A, Bharucha AE, Enk P, et al. Functional anorectal disorders. In: Drossman DA, Corraziarri E, Delvaux M, et al., editors. Rome III: The Functional Gastrointestinal disorders. 3rd Edition; Ed McLean, VA: Degnon Associates, Inc. 2006. p. 657\u2013663."},{"key":"10.1016\/j.purol.2010.08.060_bib0395","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10190-009-0009-z","article-title":"Les douleurs p\u00e9rin\u00e9ales chroniques","volume":"39","author":"Labat","year":"2009","journal-title":"Acta Encosc"},{"key":"10.1016\/j.purol.2010.08.060_bib0400","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0021-7697(04)95598-6","article-title":"Douleurs anorectales chroniques, diagnostic et strat\u00e9gie d\u2019exploration","volume":"141","author":"Bauer","year":"2004","journal-title":"J Chir (Paris)"},{"key":"10.1016\/j.purol.2010.08.060_bib0405","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.gtc.2008.06.002","article-title":"chronic anorectal and pelvic pain disorders","volume":"37","author":"Bharucha","year":"2008","journal-title":"Gastroenterol Clin North America"},{"key":"10.1016\/j.purol.2010.08.060_bib0410","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10350-006-0754-4","article-title":"Proctalgia fugax: demographic and clinical characteristics. What every doctor should know from a prospective study of 54\u00a0patients","volume":"50","author":"deParades","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.purol.2010.08.060_bib0415","first-page":"686","article-title":"Treatment of proctalgia fugax with salbutamol inhalation","volume":"91","author":"Eckardt","year":"1996","journal-title":"Am J Gastroenterol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708710003271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708710003271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:23:24Z","timestamp":1761114204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708710003271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":83,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1166708710003271"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2010.08.060","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndrome de l\u2019intestin irritable, syndrome du releveur, proctalgie fugace et douleurs pelvip\u00e9rin\u00e9ales chroniques","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2010.08.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}